A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...
Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, announced today that it has received Health Canada clearance for the aScopeTM 4 Cysto, the company’s ...
OSLO, Norway, Oct. 16, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces a highlight from the BLADDR 2020 congress, a poster presentation on new findings from the Nordic Flexible BLC ...
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Lower urinary outflow tract obstruction in a fetus may be associated with various developmental abnormalities. The obstruction may result from a number of pathologies, including urethral atresia or ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis. Injected micronized ...
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis. Injected micronized ...
COLUMBIA, Md.--(BUSINESS WIRE)--Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, announced today that it has received Health Canada clearance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results